Financials

  • Market Capitalization 10.33 M
  • Employee 8
  • Founded 2011
  • CEO Paul Kang
  • Website www.exicuretx.com
  • Headquarter Delaware, United States
  • FIGI BBG00GTJCSB4
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4794
CMMB
Chemomab Therapeutics Ltd - American Depositary Shares
1.52 USD-0.65%-24.00%-10.06%+3.05%10.93 M USD
4798
PHIO
Phio Pharmaceuticals Corp. - Common Stock
0.89 USD-13.59%-19.09%-17.59%-25.21%10.34 M USD
4801
VTGN
Vistagen Therapeutics, Inc. - Common Stock
0.25 USD0.00%+8.70%-64.79%-51.47%10.26 M USD
4807
BCDA
BioCardia, Inc. - Common Stock
0.88 USD+10.00%-10.20%+2.33%-23.81%10.01 M USD

Nouvelles